
Monday, March 25, 2024 3:55:10 PM
Just my opinion, of course.
Recent CVM News
- FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients • Business Wire • 06/18/2025 01:00:00 PM
- CEL-SCI Announces Closing of Public Offering • Business Wire • 05/23/2025 08:05:00 PM
- CEL-SCI Announces Pricing of Public Offering • Business Wire • 05/22/2025 12:14:00 AM
- CEL-SCI Announces Proposed Public Offering • Business Wire • 05/21/2025 08:05:00 PM
- CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia • Business Wire • 05/21/2025 12:00:00 PM
- CEL-SCI Announces Combination of Common Stock • Business Wire • 05/19/2025 06:40:00 PM
- CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results • Business Wire • 05/15/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:20:57 PM
- CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market • Business Wire • 04/23/2025 12:30:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (US) • 04/14/2025 02:15:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (Canada) • 04/14/2025 02:10:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (US) • 04/14/2025 02:10:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2025 05:00:21 PM
- New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses • Business Wire • 04/08/2025 01:51:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:51:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:49:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:46:47 PM
- CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients • Business Wire • 03/24/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 09:07:52 PM
- CEL-SCI Announces Closing of $2.5 Million Offering • Business Wire • 03/18/2025 08:05:00 PM
- CEL-SCI Announces Pricing of $2.5 Million Offering • Business Wire • 03/17/2025 07:24:00 PM
- CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine • Business Wire • 03/17/2025 12:00:00 PM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM